I am a urologic surgeon who specializes in surgery for men and women with cancers of the genitourinary system. Examples of the specific tumors that I treat include cancers of the bladder, prostate, kidney, and testis. My main areas of expertise include radical surgical procedures for invasive bladder cancer and reconstructive surgery of the urinary system following radical cystectomy or pelvic exenteration. Removal of the bladder, also called radical cystectomy, serves as the standard for definitive treatment of high-risk bladder tumors and can provide a cure in the majority of patients with early, invasive lesions. Function-sparing procedures (including preservation of the nerves responsible for erectile function and advanced reconstructive techniques that re-create the natural urination pathway after bladder removal) can also be performed to provide an excellent postoperative quality of life.
Read more Read less
I am actively involved in clinical and translational research to determine which treatments are most likely to maximize a patient’s chances of a cure. I am involved in ongoing studies to determine which features of a tumor predict for more or less aggressive behavior. This will help us individualize treatment for each patient based on his or her tumor’s characteristics. I am very interested in and actively study ways to improve patients’ quality of life after surgery.
I joined the Memorial Sloan Kettering faculty in 2000. I serve as the coordinator of the bladder cancer multidisciplinary working group and am co-director of the pelvic reconstruction/surgery group at Memorial Sloan Kettering. I am actively involved in urologic oncology at the national level, serving as faculty for postgraduate courses in urologic oncology for the American Urological Association. I am involved in many professional societies including the American Urological Association, the Society of Urologic Oncology, and the Society of University Surgeons. I am on several editorial boards and serve as reviewer for a variety of urology-related journals.
- Clinical Expertise: Nerve Sparing; Bladder Cancer; Kidney Cancer; Urinary Diversion and Reconstruction; Genitourinary Sarcomas
- Languages Spoken: English
- Education: MD, University of California at Los Angeles
- Residencies: Surgery - University of Southern California School of Medicine; Urology - University of Southern California School of Medicine
- Fellowships: Urologic Oncology - University of Southern California/Norris Comprehensive Cancer Center
Research is integral to our mission at Memorial Sloan Kettering, and clinical trials help us discover better forms of patient care and treatment. For you, this could mean access to a new therapy or therapy combination. Click to see a list of the trials I’m currently leading.
Read more Read less
Clinical Trials Led by Bernard H. Bochner
Clinical Trials Co-Investigated by Bernard H. Bochner
- A Phase III Study of Atezolizumab Immunotherapy versus Observation After Bladder Removal Surgery in Patients with Muscle-Invasive Bladder Cancer
- A Phase III Study of Nivolumab Immunotherapy versus Placebo to Treat High-Risk Urothelial Cancers after Surgery
- A Study of Presurgical Atezolizumab Immunotherapy with Gemcitabine and Cisplatin in Patients with Muscle-Invasive Bladder Cancer
Most major health insurers offer plans that include MSK as one of their in-network providers. If MSK is in-network, it means all our doctors are too. Medicaid and New York State Medicare also provide benefits for care at MSK.Learn more